Hagerty, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on December 31, 2025, with the report filed on January 2, 2026. Hagerty, Inc. (the "Company") consummated a previously announced fronting arrangement involving its strategic partner, Markel Group Inc., and various subsidiaries including The Hagerty Group, LLC ("OpCo"), Hagerty Insurance Agency, LLC ("HIA"), Hagerty Reinsurance Limited ("Hagerty Re"), and Essentia Insurance Company ("Essentia").
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses exclusively on the execution of material definitive agreements.
Material Changes and Agreements
On December 31, 2025, the Company entered into or amended four key agreements:
- Sixth Amended and Restated Master Relationship Agreement: Amended the relationship with Markel, extending the term through December 31, 2028. It retains OpCo's option to purchase Essentia between January 1, 2026, and January 1, 2028, and removes certain restrictive covenants, including mutual exclusivity provisions.
- Seventh Amended and Restated Limited Liability Company Agreement: Executed with Markel and OpCo members to remove restrictive covenants, specifically exclusivity provisions relating to the businesses of the Company and its subsidiaries.
- General Agency Agreement: Grants HIA authority to produce, bind, service, and manage Essentia policies, which will be 100% reinsured by Hagerty Re. This expands HIA's administrative authority over the program business.
- Quota Share Reinsurance Agreement: Effective January 1, 2026, Hagerty Re will assume 100% of the risk on policies issued by Essentia on or after that date, as well as unexpired policies issued prior to that date for losses occurring on or after January 1, 2026.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future financial performance, or specific risk factors beyond the structural changes to the business relationships. The primary operational change is the shift in risk assumption to Hagerty Re effective January 1, 2026, and the removal of exclusivity covenants which may alter competitive dynamics.
Key Facts for Investor Verification
- Verify the specific terms and valuation of the option for OpCo to purchase Essentia exercisable between 2026 and 2028.
- Confirm the impact of removing mutual exclusivity provisions on Hagerty's competitive position and Markel's other business interests.
- Review the full text of the Quota Share Agreement to understand the specific reinsurance mechanics and capital implications for Hagerty Re.
- Monitor future filings for financial impact analysis resulting from the 100% risk assumption by Hagerty Re starting January 1, 2026.